Cargando…
Determination of intracellular protein–ligand binding affinity by competition binding in-cell NMR
Structure-based drug development suffers from high attrition rates due to the poor activity of lead compounds in cellular and animal models caused by low cell penetrance, off-target binding or changes in the conformation of the target protein in the cellular environment. The latter two effects cause...
Autores principales: | Luchinat, Enrico, Barbieri, Letizia, Cremonini, Matteo, Pennestri, Matteo, Nocentini, Alessio, Supuran, Claudiu T., Banci, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489230/ https://www.ncbi.nlm.nih.gov/pubmed/34605430 http://dx.doi.org/10.1107/S2059798321009037 |
Ejemplares similares
-
Intracellular Binding/Unbinding Kinetics of Approved
Drugs to Carbonic Anhydrase II Observed by in-Cell NMR
por: Luchinat, Enrico, et al.
Publicado: (2020) -
Drug Screening in Human Cells by NMR Spectroscopy Allows the Early Assessment of Drug Potency
por: Luchinat, Enrico, et al.
Publicado: (2020) -
In situ ligand restraints from quantum-mechanical methods
por: Liebschner, Dorothee, et al.
Publicado: (2023) -
Protein in-cell NMR spectroscopy at 1.2 GHz
por: Luchinat, Enrico, et al.
Publicado: (2021) -
Real-Time Quantitative In-Cell NMR: Ligand Binding
and Protein Oxidation Monitored in Human Cells Using Multivariate
Curve Resolution
por: Luchinat, Enrico, et al.
Publicado: (2020)